Skip to content

Cervical Length in Cases of Placenta Previa

Value of Third Trimester Cervical Length Measurement in Predicting Risk and Severity if Antepartum Haemorrhage in Cases of Placenta Previa

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03451136
Enrollment
80
Registered
2018-03-01
Start date
2018-03-01
Completion date
2018-07-15
Last updated
2018-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Placenta Previa

Keywords

Placenta previa, Cervical length, Antepartum haemorrhage

Brief summary

This study establishes the relationship between cervical length and whether it can be used to predict haemorrhage and preterm delivery in cases of placenta previa.

Detailed description

Some studies have reported an association between ultrasonographic decreased cervical length and the likelihood of complications as antepartum or post-partum haemorrhage requiring an emergency caesarean section (CS) . The safety of trans-vaginal scanning is not in doubt, and the technique now has widespread acceptance. As a consequence, the clinical presentation of placenta previa has changed and most low lying placentas are diagnosed during the second trimester anomaly scan. The objective of this study was to establish if there is a relation between transvaginal ultrasonographic measurement of cervical length in cases of placenta previa and whether it can be used as a predictor for antepartum haemorrhage or not.

Interventions

None listed

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
25 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

1. Age: 20-45 years old 2. Single Pregnancy 3. Fetal gestational age 28 to \< 36 weeks 4. Normal amniotic fluid index (AFI) 5. Diagnosis of placenta previa by pelvic ultrasound that was confirmed when the lower placental edge overlies the internal cervical os on transvaginal ultrasound (TVS).

Exclusion criteria

1. Threatened preterm labor and maternal use of vaginal progesterone. 2. Preterm premature rupture of membranes; 3. Polyhydramnios; 4. Presence of cercelage and history of cervical cone biopsy which both affect cervical length. 5. Diagnosis of multiple fetal anomalies; 6. Women with other risk factors for intra-partum hemorrhage

Design outcomes

Primary

MeasureTime frameDescription
Cervical length measured in mm in relation to antepartum haemorrhage4 monthsTo find out the relationship between cervical length measured by transvaginal ultrasound and occurrence of antepartum hemorrhage in cases of placenta previa.

Secondary

MeasureTime frameDescription
Need for blood transfusion4 monthsYes or no and no.of packed units
Need for caesarean hysterectomy4 monthsYes or no
Type of cesarean delivery4 monthsElective or emergency cesarean delivery
Need for neonatal ICU4 monthsYes or no

Contacts

Primary ContactMarwa Mohamed Eid, PhD
Marwameid2014@gmail.com01001225079
Backup ContactHisham Mamdouh Haggag, PhD
Hmhaggag@kasralainy.edu.eg01224460134

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026